The pregnant psychiatric patient requires a modified clinical approach that maintains rather than suspends treatment. The fundamental principle: untreated psychiatric illness in pregnancy is not safe. Untreated depression carries fetal and maternal risks. Untreated bipolar disorder carries substantial relapse and decision-making risk. Untreated psychotic illness threatens safety of both mother and child. The question is what to treat with, not whether to treat.
Risk-benefit framing grounds the conversation. "Both untreated illness and medication exposure have risks. Let's think about which combination is safest for both you and the baby." Honest acknowledgment of trade-offs builds the alliance that makes shared decision-making possible. The patient deserves the full picture, not a curated version.
Preferred agents: sertraline (most extensive SSRI pregnancy data); lamotrigine for bipolar maintenance (with dose adjustment because pregnancy alters clearance); older antipsychotics with extensive data (haloperidol) or specific atypicals (olanzapine has substantial registry data, with metabolic considerations); lithium with careful management (small Ebstein's anomaly risk requires fetal echocardiogram).
Avoided when alternatives exist: valproate (substantial teratogenicity — neural tube defects, cognitive impairment); paroxetine (cardiac malformation signal); benzodiazepines (first-trimester cleft palate signal; third-trimester floppy baby and withdrawal). For the woman of childbearing potential, plan medication choices with possible pregnancy in mind, not just current pregnancy.
OB coordination from the start. Share medication decisions and rationale with the OB team. Fetal echocardiogram if on lithium. Adjusted dosing during pregnancy as physiology changes. Joint planning for delivery and immediate postpartum period.
Postpartum is the highest-risk period for relapse. Plan for it during pregnancy. Prophylactic strategies for bipolar disorder. Close monitoring for depression in the first weeks. Specific watch for postpartum psychosis (medical emergency, often requiring hospitalization). The transition from pregnancy to postpartum is when most relapses occur; don't wait for them to plan.
Brexanolone and zuranolone are FDA-approved specifically for postpartum depression with rapid onset — major new tools for this period.